| BMC Infectious Diseases | |
| Clinical features and outcome of acute hepatitis B in pregnancy | |
| Qiang Li3  Wen-Wen Li2  Jin-Hong Yu3  Li Liu3  Di Xiao3  Shuang-Shuang Xie3  Cai-Xia Liu3  Chao Sun3  Yong-Tao Han1  | |
| [1] Department of Pharmacy, Qilu Hospital, Shandong University, Jinan, China;Unit of Disease Control Genome Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan;Division of Liver Disease, Jinan Infectious Disease Hospital, Shandong University, Jinan, China | |
| 关键词: Chronicity; Hepatitis B surface antigen; Outcome; Clinical features; Pregnancy; Acute hepatitis B; | |
| Others : 1127446 DOI : 10.1186/1471-2334-14-368 |
|
| received in 2014-03-03, accepted in 2014-06-30, 发布年份 2014 | |
PDF
|
|
【 摘 要 】
Background
The impact of pregnancy on the clinical course of acute hepatitis B (AHB) is still largely unclear, mainly because most studies have not included matched controls. This study was conducted to investigate the clinical features and outcome of AHB in pregnancy using matched controls.
Methods
Consecutive AHB inpatients who were admitted to Jinan Infectious Disease Hospital, Jinan, between January 2006 and December 2010 were evaluated and followed. Demographic data, clinical manifestations, and results of laboratory tests were compared between pregnant patients and age and sex matched non-pregnant patients at admission, discharge, and final follow-up.
Results
A total of 618 AHB inpatients were identified during the study period. 22 pregnant patients and 87 age and sex matched non-pregnant patients were enrolled in this study. Prodromal fever was less common (0% vs. 20.7%, P = 0.02), serum alanine aminotransferase levels were significantly lower, and HBsAg > 250 IU/mL rate and serum bilirubin levels were significantly higher in pregnant patients than in non-pregnant patients. After a mean (range) of 7(5.2-8.3) months follow-up, 18.2% pregnant patients and 4.6% non-pregnant patients were still HBsAg positive (P = 0.03). For pregnant patients, the relative risk (95% confidence interval) of HBsAg positive at the end of follow-up was 4.6 (1.1-20.2). The median (95% confidence interval) days of HBsAg seroclearance form disease onset in pregnant and non-pregnant patients were 145.0 (110.5-179.5) and 80.0 (62.6-97.4), respectively.
Conclusions
The HBsAg loss and seroconversion were delayed and lower in pregnant patients. Pregnancy might be a possible risk of chronicity following acute HBV infection.
【 授权许可】
2014 Han et al.; licensee BioMed Central Ltd.
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| 20150220161656941.pdf | 267KB | ||
| Figure 1. | 55KB | Image |
【 图 表 】
Figure 1.
【 参考文献 】
- [1]Liang TJ: Hepatitis B: the virus and disease. Hepatology 2009, 49(5 Suppl):S13-S21.
- [2]Steven MM: Pregnancy and liver disease. Gut 1981, 22(7):592-614.
- [3]Cossart YE: The outcome of hepatitis B virus infection in pregnancy. Postgrad Med J 1977, 53(624):610-613.
- [4]Nayak NC, Panda SK, Datta R, Zuckerman AJ, Guha DK, Madanagopalan N, Buckshee K: Aetiology and outcome of acute viral hepatitis in pregnancy. J Gastroenterol Hepatol 1989, 4(4):345-352.
- [5]Jaiswal SP, Jain AK, Naik G, Soni N, Chitnis DS: Viral hepatitis during pregnancy. Int J Gynaecol Obstet 2001, 72(2):103-108.
- [6]Khuroo MS, Kamili S: Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy. J Viral Hepat 2003, 10(1):61-69.
- [7]Heijtink RA, Paulij W, Van Roosmalen M, Hellings JA, Niesters HG, Schalm SW, Osterhaus AD: Characteristics of the early phase of chronicity in acute hepatitis B infection. J Med Virol 1999, 57(4):331-336.
- [8]Sookoian S: Liver disease during pregnancy: acute viral hepatitis. Ann Hepatol 2006, 5(3):231-236.
- [9]Hyams KC: Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995, 20(4):992-1000.
- [10]Ratnam D, Visvanathan K: New concepts in the immunopathogenesis of chronic hepatitis B: the importance of the innate immune response. Hepatol Int 2008, 2(1):12-18.
- [11]Bertoletti A, Gehring AJ: The immune response during hepatitis B virus infection. J Gen Virol 2006, 87(Pt 6):1439-1449.
- [12]Hadler SC, Judson FN, O’Malley PM, Altman NL, Penley K, Buchbinder S, Schable CA, Coleman PJ, Ostrow DN, Francis DP: Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodeficiency virus infection. J Infect Dis 1991, 163(3):454-459.
- [13]Gatanaga H, Yasuoka A, Kikuchi Y, Tachikawa N, Oka S: Influence of prior HIV-1 infection on the development of chronic hepatitis B infection. Eur J Clin Microbiol Infect Dis 2000, 19(3):237-239.
- [14]Fujiwara K, Yokosuka O, Kojima H, Kanda T, Saisho H, Hirasawa H, Suzuki H: Importance of adequate immunosuppressive therapy for the recovery of patients with “life-threatening” severe exacerbation of chronic hepatitis B. World J Gastroenterol 2005, 11(8):1109-1114.
- [15]Navaneethan U, Al Mohajer M, Shata MT: Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int 2008, 28(9):1190-1199.
- [16]Mohite BJ, Rath S, Bal V, Kamat SA, Marathe SN, Zuckerman AJ, Kamat RS: Mechanisms of liver cell damage in acute hepatitis B. J Med Virol 1987, 22(3):199-210.
- [17]Centers for Disease Control and Prevention: Guidelines For Viral Hepatitis Surveillance And Case Management. Atlanta, GA: Centers for Disease Control and Prevention; 2005. http://www.cdc.gov/hepatitis/PDFs/2005Guidlines-Surv-CaseMngmt.pdf webcite. Accessed January 6, 2013
- [18]Sharif O, Krishnan PV, Thekdi AD, Gordon SC: Acute hepatitis B in an urban tertiary care hospital in the United States: a cohort evaluation. J Clin Gastroenterol 2013, 47(9):e87-e90.
- [19]Li Q, Li WW, Yang X, Fan WB, Yu JH, Xie SS, Liu L, Ma LX, Chen SJ, Kato N, Li Q, Li WW, Yang X, Fan WB, Yu JH, Xie SS, Liu L, Ma LX, Chen SJ, Kato N: Type 2 diabetes and hepatocellular carcinoma: A case–control study in patients with chronic hepatitis B. Int J Cancer 2012, 131(5):1197-1202.
- [20]Li Q, Yu CH, Yu JH, Liu L, Xie SS, Li WW, Yang X, Fan WB, Gai ZT, Chen SJ, Kato N: ABO Blood Group and the Risk of Hepatocellular Carcinoma: A Case–control Study in Patients with Chronic Hepatitis B. PLoS ONE 2012, 7(1):e29928.
- [21]Ogoina D: Fever, fever patterns and diseases called ‘fever’–a review. J Infect Public Health 2011, 4(3):108-124.
- [22]O’Grady NP, Barie PS, Bartlett JG, Bleck T, Carroll K, Kalil AC, Linden P, Maki DG, Nierman D, Pasculle W, Masur H: Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America. Crit Care Med 2008, 36(4):1330-1349.
- [23]Polson J, Lee WM: AASLD position paper: the management of acute liver failure. Hepatology 2005, 41(5):1179-1197.
- [24]Lok AS, McMahon BJ: Chronic hepatitis B. Hepatology 2007, 45(2):507-539.
- [25]Jonas MM: Hepatitis B and pregnancy: an underestimated issue. Liver Int 2009, 29(Suppl 1):133-139.
- [26]Spencer SJ, Mouihate A, Galic MA, Pittman QJ: Central and peripheral neuroimmune responses: hyporesponsiveness during pregnancy. J Physiol 2008, 586(2):399-406.
- [27]Nguyen G, Garcia RT, Nguyen N, Trinh H, Keeffe EB, Nguyen MH: Clinical course of hepatitis B virus infection during pregnancy. Aliment Pharmacol Ther 2009, 29(7):755-764.
- [28]Soderstrom A, Norkrans G, Lindh M: Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scand J Infect Dis 2003, 35(11–12):814-819.
- [29]Ter Borg MJ, Leemans WF, De Man RA, Janssen HL: Exacerbation of chronic hepatitis B infection after delivery. J Viral Hepat 2008, 15(1):37-41.
- [30]Bhatia V, Singhal A, Panda SK, Acharya SK: A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology 2008, 48(5):1577-1585.
- [31]Sonneveld MJ, Zoutendijk R, Janssen HL: Hepatitis B surface antigen monitoring and management of chronic hepatitis B. J Viral Hepat 2011, 18(7):449-457.
- [32]Chisari FV, Ferrari C: Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995, 13:29-60.
- [33]Limdi JK, Hyde GM: Evaluation of abnormal liver function tests. Postgrad Med J 2003, 79(932):307-312.
- [34]Billing BH, Black M: Bilirubin metabolism. Gut 1969, 10(4):250-254.
- [35]Johnson AD, Kavousi M, Smith AV, Chen MH, Dehghan A, Aspelund T, Lin JP, Van Duijn CM, Harris TB, Cupples LA, Uitterlinden AG, Launer L, Hofman A, Rivadeneira F, Stricker B, Yang Q, O'Donnell CJ, Gudnason V, Witteman JC: Genome-wide association meta-analysis for total serum bilirubin levels. Hum Mol Genet 2009, 18(14):2700-2710.
- [36]Bacq Y, Zarka O, Brechot JF, Mariotte N, Vol S, Tichet J, Weill J: Liver function tests in normal pregnancy: a prospective study of 103 pregnant women and 103 matched controls. Hepatology 1996, 23(5):1030-1034.
- [37]Luquita MG, Catania VA, Pozzi EJ, Veggi LM, Hoffman T, Pellegrino JM, Ikushiro S, Emi Y, Iyanagi T, Vore M, Mottino AD: Molecular basis of perinatal changes in UDP-glucuronosyltransferase activity in maternal rat liver. J Pharmacol Exp Ther 2001, 298(1):49-56.
PDF